Alnylam Pharmaceuticals, Inc. (ALNY) Reports Q4 Loss of $0.33

February 9, 2012 4:00 PM EST Send to a Friend
Get Alerts ALNY Hot Sheet
Trade ALNY Now!
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) reported Q4 EPS of ($0.33), $0.01 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $20.5 million versus the consensus estimate of $20.9 million.

For earnings history and earnings-related data on Alnylam Pharmaceuticals, Inc. (ALNY) click here.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Earnings

Related Entities

Earnings

Add Your Comment